Published in Histochemistry on January 01, 1989
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet (2000) 6.49
Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol (1997) 3.11
Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 2.73
Impaired cellular immunity in kwashiorkor with improvement after therapy. Br Med J (1971) 2.29
Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J (2000) 2.16
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans. Br J Haematol (1968) 1.93
Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.86
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68
Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation (2001) 1.64
Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation (1995) 1.61
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X") Circulation (1989) 1.57
Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. Med J Aust (1997) 1.52
Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol (1970) 1.52
Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Eur Heart J (2002) 1.51
Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation (1997) 1.48
A new method for delivering radioactive cytotoxic agents in solid cancers. Int J Radiat Oncol Biol Phys (1994) 1.47
Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther (1997) 1.47
Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J (1970) 1.47
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium. Cardiovasc Res (2001) 1.46
Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation (2000) 1.46
Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation (1992) 1.45
ACE inhibition improves vagal reactivity in patients with heart failure. Am Heart J (1990) 1.45
Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol (1989) 1.45
External beam radiation after stent implantation increases neointimal hyperplasia by augmenting smooth muscle cell proliferation and extracellular matrix accumulation. J Am Coll Cardiol (1999) 1.41
Refractory oedema in congestive heart failure: a contributory role of loop diuretics? J Intern Med (1995) 1.40
Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol (1992) 1.39
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function. Cardiovasc Drugs Ther (1992) 1.39
Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Eur J Nucl Med (1992) 1.38
Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound. Catheter Cardiovasc Interv (2001) 1.38
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res (1984) 1.38
Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem (1999) 1.37
Physiological neutrophilia of pregnancy is not associated with a rise in plasma granulocyte colony-stimulating factor (G-CSF) Am J Hematol (1995) 1.37
Investigation and management of fetomaternal alloimmune thrombocytopenia. Aust N Z J Obstet Gynaecol (2000) 1.37
Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol (2000) 1.36
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol (1997) 1.30
Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica (2006) 1.29
Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1998) 1.23
Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation (1984) 1.23
Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol (1995) 1.21
Morphological alterations and functional changes of interhepatocellular junctions induced by bile duct ligation. Cell Tissue Res (1977) 1.21
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation (2000) 1.21
Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany. Am J Respir Crit Care Med (1995) 1.19
Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation (1983) 1.19
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart (2002) 1.19
Influence of dipyridamol (Persantin) on myocardial adenosine metabolism. J Mol Cell Cardiol (1970) 1.18
The possible role of hemoconcentration in the etiology of myocardial infarction. Am Heart J (1967) 1.17
Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol (1983) 1.16
HERG potassium channel activation is shifted by phorbol esters via protein kinase A-dependent pathways. J Biol Chem (1998) 1.16
Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol (1992) 1.15
Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.14
Sustained human chemosignal unconsciously alters brain function. Neuroreport (2001) 1.13
Mechanisms of thrombocytopenia in malignant tertian malaria. Br Med J (1973) 1.13
Mechanism of early "pump" failure of the ischemic heart: possible role of adenosine triphosphate depletion and inorganic phosphate accumulation. Am J Cardiol (1977) 1.12
Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail (2001) 1.11
Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells. Development (1999) 1.09
A note on the folate content of uncooked maize. S Afr Med J (1970) 1.08
Folic acid binding by serum and milk. Am J Clin Nutr (1968) 1.07
Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol (2000) 1.06
Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. Biochem Biophys Res Commun (1999) 1.05
I-, MN- and Pr1/Pr2-activity of human erythrocyte glycoprotein fractions obtained by ficin treatment. Vox Sang (1971) 1.05
Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation. Eur Heart J (1992) 1.05
Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa. Circulation (2000) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
Endocarditis caused by a Leptotrichia buccalis-like bacterium in a patient with a prosthetic aortic valve. Eur J Clin Microbiol Infect Dis (1993) 1.04
Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol (1988) 1.03
Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation (2000) 1.03
The linearity of the end-systolic pressure-volume relationship in man and its sensitivity for assessment of left ventricular function. Circulation (1981) 1.03
Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J Pediatr (1973) 1.03
Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.03
Intracoronary thrombolysis in acute myocardial infarction: duration of ischemia as a major determinant of late results after recanalization. Am J Cardiol (1982) 1.02
Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation (1984) 1.01
Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol (2000) 1.01
Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET. Alcohol Clin Exp Res (1990) 1.01
The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol (2001) 1.01
Silent myocardial ischemia as a potential link between lack of premonitoring symptoms and increased risk of cardiac arrest during physical stress. Am J Cardiol (1990) 1.00
Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats : protection by methionine and aggravation by folates. Life Sci (1982) 1.00
Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J (1997) 1.00
Pressure measurements in the terminal vascular bed of the epimyocardium of rats and cats. Circ Res (1981) 0.99
Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med (2001) 0.98
Disseminated intravascular coagulation with fatal haemorrhage in cerebral malaria. Br Med J (1970) 0.97
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ Res (1984) 0.97
Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J Am Coll Cardiol (1998) 0.97
Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm (1979) 0.97
Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J (2001) 0.96
Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation (1995) 0.96
Relationship between the degree of coronary artery disease and of left ventricular function and the duration of the QT-interval in ECG. Eur Heart J (1986) 0.96
Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci (1990) 0.96
[Nutrition in pregnancy]. Gynakologe (1987) 0.96
The anaemia of erythropoietic prophyria with the description of the disease in an elderly patient. Br J Haematol (1965) 0.96